Toward Identifying the Zinc-Responsive Child: Biomarker Challenges, Growth Response, and Precision Supplementation
Year: 2026
Type: article
Abstract: Background/Objectives: Available zinc biomarkers do not reliably identify children likely to benefit from supplementation. This review examined biomarker responsiveness to supplementation, associations with growth, and evidence for differential treatment benefit. Methods: This critical narrative review examined ten purposively selected sentinel reports from eight study families, predominantly involving preterm infants and children aged ≤3 years. Reports were identified through a structured PubMed/MEDLINE search of 2021–2025 publications and appraised using design-specific Joanna Briggs Institute tools. Results: Serum or plasma zinc often increased after supplementation without a corresponding improvement in growth. Community-based growth findings were inconsistent; the modest benefit observed with a multinutrient formulation could not be attributed to zinc alone. Neonatal observational findings were mixed and could not establish a causal effect on growth. Evidence from studies involving children with cystic fibrosis or chronic kidney disease was insufficient to establish a growth benefit. Within the selected corpus, no baseline biomarker was validated as a predictor of growth response. Sample sizes and follow-up limited conclusions about safety, particularly uncommon or delayed adverse effects. Conclusions: Identifying the zinc-responsive child may be best approached through a multidimensional assessment integrating standardized biomarkers, longitudinal growth, diet, inflammation, clinical context, and intervention characteristics, while future research continues to refine and validate predictive approaches.
Source: Nutrients
DOI: 10.3390/nu18223805
Language: English
Topic: Trace Elements in Health
Subfield: Nutrition and Dietetics
Field: Nursing
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7234394790
